Janus Henderson Global Life Sciences Fund Class T (JAGLX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
64.97
-1.10 (-1.66%)
Aug 1, 2025, 8:09 AM EDT
-1.66%
Fund Assets4.40B
Expense Ratio0.92%
Min. Investment$2,500
Turnover35.00%
Dividend (ttm)3.87
Dividend Yield5.85%
Dividend Growth33.40%
Payout FrequencyAnnual
Ex-Dividend Daten/a
Previous Close66.07
YTD Return-3.71%
1-Year Return-8.12%
5-Year Return36.49%
52-Week Low61.32
52-Week High82.05
Beta (5Y)0.63
Holdings108
Inception DateDec 31, 1998

About JAGLX

The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio manager believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.

Fund Family Janus Henderson
Category Health
Stock Exchange NASDAQ
Ticker Symbol JAGLX
Share Class Class T
Index MSCI World/Health Care NR

Performance

JAGLX had a total return of -8.12% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.71%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

SymbolShare ClassExpense Ratio
JFNNXClass N0.68%
JFNIXClass I0.77%
JNGLXClass D0.80%
JFNAXClass A0.98%

Top 10 Holdings

39.11% of assets
NameSymbolWeight
Eli Lilly and CompanyLLY9.78%
UnitedHealth Group IncorporatedUNH5.36%
AstraZeneca PLCAZN4.07%
Boston Scientific CorporationBSX3.20%
SanofiSAN3.18%
Abbott LaboratoriesABT3.06%
Vertex Pharmaceuticals IncorporatedVRTX2.93%
AbbVie Inc.ABBV2.57%
Amgen Inc.AMGN2.51%
Novartis AG ADRNVSN.MX2.44%

Dividend History

Ex-DividendAmountPay Date
Dec 6, 2024$3.86839Dec 6, 2024
Dec 7, 2023$2.89991Dec 7, 2023
Dec 20, 2022$0.09366Dec 20, 2022
Dec 20, 2021$6.73381Dec 20, 2021
Dec 17, 2020$5.50316Dec 17, 2020
Dec 17, 2019$3.76557Dec 17, 2019
Full Dividend History